DGAP-Adhoc: Cardea Europe AG: Cardea Corporate Holdings Inc. stockt Beteiligung an Cardea Europe AG auf 100 Prozent auf

Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014

Cardea Corporate Holdings Inc. stockt Beteiligung an Cardea Europe AG auf 100 Prozent auf

4. März 2022 - Frankfurt. Cardea Corporate Holdings Inc., hat heute ihre bestehende Option (vergl. Ad-Hoc vom 05.12.2021) zum Erwerb der verbleibenden 51 Prozent an der Cardea Europe AG ausgeübt. Die Gesellschaft hält nunmehr 100 Prozent an der Cardea Europe. Über den Kaufpreis wurde Stillschweigen vereinbart.

Cardea Europe AG

Lurgiallee 14

D-60439 Frankfurt am Main

Deutschland

Disclaimer

Safe Harbor Statement

No action has been taken that would permit an offering of the securities or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

If any statements in this document contain forward-looking statements, such statements do not represent facts and are characterized by the words 'will', 'expect', 'believe', 'estimate', 'intend', 'aim', 'assume' or similar expressions. Such statements express the intentions, opinions or current expectations and assumptions of DESIAG and/or CARDEA EUROPE AG and the persons acting together with DESIAG and/or CARDEA EUROPE AG. Such forward-looking statements are based on current plans, estimates and forecasts which DESIAG and/or CARDEA EUROPE AG and the persons acting together with DESIAG and / or CARDEA EUROPE AG have made to the best of their knowledge, but which do not claim to be correct in the future. Forward-looking statements are subject to risks and uncertainties that are difficult to predict and usually cannot be influenced by DESIAG and / or CARDEA EUROPE AG or the persons acting together with DESIAG and / or CARDEA EUROPE AG. It should be kept in mind that the actual events or consequences may differ materially from those contained in or expressed by such forward-looking statements.

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. The information in this announcement is subject to change.